As of April 19, 2025, Milestone Pharmaceuticals (MIST) has a market cap of $47.426 million USD. According to our data, Milestone Pharmaceuticals is ranked No.8111 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $47.43 M |
-62.32%
|
Dec 31, 2024 | $0.13 B |
41.32%
|
Dec 29, 2023 | $89.06 M |
-57.83%
|
Dec 30, 2022 | $0.21 B |
-39.54%
|
Dec 31, 2021 | $0.35 B |
-2.24%
|
Dec 31, 2020 | $0.36 B |
-58.15%
|
Dec 31, 2019 | $0.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
Market Cap | = | MIST Stock Price | * | MIST Shares Outstanding |
= | $0.89 | * | 53.35 M | |
= | $47.43 M |